Return‐to‐baseline multiple imputation for missing values in clinical trials-Reference-Cited by-同舟云学术

Return‐to‐baseline multiple imputation for missing values in clinical trials

Published:2022-01-05 Issue:3 Volume:21 Page:641-653
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Qu Yongming¹^ORCID,Dai Biyue¹

Affiliation:

1. Department of Statistics, Data and Analytics Lilly Corporate Center, Eli Lilly and Company Indianapolis Indiana USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2191

Reference22 articles.

1. ICH E9 (R1).Addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials . EMA/CHMP/ICH/436221/2017 Step 5 (17 February 2020);2020.

2. Defining estimands using a mix of strategies to handle intercurrent events in clinical trials

3. Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic

4. European Medicines Agency Committee for Medicinal Products for Human Use (CHMP).Guideline on missing data in confirmatory clinical trials. EMA/CPMP/EWP/1776/99 Rev. 1;2010.

5. Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference‐Base Centred Multiple Imputation;Pharmaceutical Statistics;2024-07-16

2. Prevalence and predictors of use of long-term and short-acting reversible contraceptives among women of reproductive age in Wakiso and Hoima districts, Uganda: A cross-sectional study;PLOS Global Public Health;2023-12-11

3. Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts;Therapeutic Innovation & Regulatory Science;2023-10-07

4. Statistical methods for handling missing data to align with treatment policy strategy;Pharmaceutical Statistics;2023-03-27

5. Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials;Therapeutic Innovation & Regulatory Science;2022-05-24